• Western blot analysis of KLF7 Antibody. The lane on the right is blocked with the KLF7 peptide.

Anti-KLF7 antibody (171-220 aa) (STJ93848)

SKU:
STJ93848

Current Stock:
Host: Rabbit
Applications: WB/IHC
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Krueppel-like factor 7 (171-220 aa) is suitable for use in Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-P 1:50-300
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: KLF7
Gene ID: 8609
Uniprot ID: KLF7_HUMAN
Immunogen Region: 171-220 aa
Specificity: KLF7 Polyclonal Antibody detects endogenous levels of KLF7 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human KLF7 at the amino acid range 171-220
Function Transcriptional factor. Plays a critical role in neuronal morphogenesis and survival of sensory neurons. Represses the corneal epithelium differentiation. Acts also as a metabolic regulator, by modulating insulin sensitivity in pancreatic beta cells and skeletal muscle cells. Inhibits transcriptional inducers of adipogenesis and has a repressive role in the expression of several adipokines, including leptin.
Protein Name Krueppel-Like Factor 7
Ubiquitous Krueppel-Like Factor
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Krueppel-Like Factor 7 antibody
Anti-Ubiquitous Krueppel-Like Factor antibody
Anti-KLF7 antibody
Anti-UKLF antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance